PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced the setup of a €10 million loan granted by its top shareholder, Financière de la Montagne. A BioAlliance Pharma shareholder since 2008, today its top shareholder and member of its Board of Directors, Financière de la Montagne thus confirms its commitment to the Company.
Help employers find you! Check out all the jobs and post your resume.
